M. McDonnell (Oranmore (Co Galway), Ireland), Y. Varol (Izmir, Turkey), J. Vestbo (Manchester (Greater Manchester), United Kingdom), M. Barrecheguren Fernandez (Barcelona, Spain)
Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD
J. Voorham (Singapore, Singapore), M. Kerkhof (Singapore, Singapore), M. Scuri (Parma, Italy), S. Vezzoli (Parma, Italy), I. Valente (Parma, Italy), A. Papi (Ferrara, Italy), C. Vogelmeier (Marburg, Germany), D. Singh (Manchester, United Kingdom), L. Fabbri (Modena, Italy), J. Kocks (Singapore, Singapore), D. Price (Singapore, Singapore)
|   |
Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
M. Arjomandi (San Francisco, United States of America), S. Zeng (San Francisco, United States of America), C. Huang (San Francisco, United States of America), P. Blanc (San Francisco, United States of America)
| |
Late Breaking Abstract - The association of osteoporosis with mortality and symptom burden in a COPD cohort. The HUNT Study, Norway.
S. Vikjord (Levanger, Norway), B. Brumpton (Trondheim, Norway), X. Mai (Trondheim, Norway), L. Bhatta (Trondheim, Norway), A. Langhammer (Levanger, Norway)
| |
Late Breaking Abstract - Does medication exacerbate comorbidities in chronic obstructive pulmonary disease? A prevalence study of neuroleptic intake
V. Cabibel (Montpellier, France), N. Héraud (Lodève, France), A. Varray (Montpellier, France), F. Alexandre (Lodève, France)
| |
Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure
D. Price (Singapore, Singapore), R. Ryan (Singapore, Singapore), R. Fogel (East Hanover, NJ, United States of America), H. Cao (East Hanover, NJ, United States of America), J. W.H. Kocks (singapore, Singapore), P. Agostoni (Milan, Italy), C. Kook Rhee (Seoul, Republic of Korea), J. Hurst (London, United Kingdom), R. Jones (Singapore, Singapore), K. Kostikas (Basel, Switzerland)
| |
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) and M. catarrhalis (Mcat) adjuvanted vaccines in adults
P. Van Damme (Antwerp, Belgium), G. Leroux-Roels (Ghent, Belgium), C. Vandermeulen (Leuven, Belgium), I. De Ryck (Siena, Italy), A. Tasciotti (Siena, Italy), M. Dozot (Rixensart, Belgium), L. Moraschini (Siena, Italy), M. Testa (Siena, Italy), A. Arora (Siena, Italy)
| |
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD)
T. Wilkinson (Southampton, United Kingdom), S. Schembri (Dundee, United Kingdom), C. Brightling (Leicester, United Kingdom), N. Bakerly (Salford, United Kingdom), W. Macnee (Edinburgh, United Kingdom), L. Rombo (Uppsala, Sweden), J. Hedner (Göteborg, Sweden), M. Allen (Stoke-on-Trent, United Kingdom), P. Walker (Liverpool, United Kingdom), I. De Ryck (Siena, Italy), A. Tasciotti (Siena, Italy), D. Casula (Siena, Italy), M. Testa (Siena, Italy), A. Arora (Siena, Italy)
| |
Late Breaking Abstract - Overlap of SGRQ and CAT-defined chronic mucus hypersecretion in the SPIROMICS cohort: implications for digital health
M. Stott-Miller (Uxbridge, United Kingdom), H. Müllerová (Uxbridge, United Kingdom), B. Miller (King of Prussia, United States of America), A. Lazaar (King of Prussia, United States of America), M. Tabberer (Uxbridge, United Kingdom), C. El Baou (Uxbridge, United Kingdom), T. Keeley (Uxbridge, United Kingdom), F. Martinez (New York, United States of America), M. Han (Ann Arbor, United States of America), R. Tal-Singer (King of Prussia, United States of America)
| |
The Aetiology of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD): A Systematic Literature Review (SLR)
J. Willson (Rotterdam, Netherlands), E. Bunge (Rotterdam, Netherlands), K. Pascoe (Brentford, United Kingdom), D. King (Brentford, United Kingdom), H. Müllerová (Uxbridge, United Kingdom)
| |
Bronchiectasis in exacerbation of COPD: differences between genders
E. Rodriguez Jimeno (Madrid, Spain), G. Sánchez Muñoz (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), F. Pedraza Serrano (Madrid, Spain), V. Gallo González (Madrid, Spain), A. López De Andrés (Madrid, Spain), R. Jiménez García (Madrid, Spain), V. Hernández Barrera (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Díez (Madrid, Spain)
| |
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
M. Kacem (Ariena, Tunisia), I. Bachouche (Ariena, Tunisia), F. Chermiti (Ariena, Tunisia), N. Belloumi (Ariena, Tunisia), Y. Hdidène (Ariena, Tunisia), S. Fenniche (Ariena, Tunisia)
| |
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
B. Cushen (Dublin, Ireland), G. Greene (Dublin, Ireland), E. Mac Hale (Dublin, Ireland), L. Tompkins (Dublin, Ireland), I. Sulaiman (Dublin, Ireland), F. Boland (Dublin, Ireland), E. Kelly (Dublin, Ireland), R. Costello (Dublin, Ireland)
| |
Bronchiectasis in COPD: increased susceptibility of the airways to aggressive agents?
M. Corso Pereira (Campinas, Brazil), S. Silva Doria (Campinas, Brazil), M. Moreira (Campinas, Brazil), P. Tonidandel (Campinas, Brazil), E. De Capitani (Campinas, Brazil), I. Paschoal (Campinas, Brazil)
| |
Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), J. Ali (Telford, United Kingdom), M. Radzali (Telford, United Kingdom), J. Ahmed (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), A. Makan (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
| |
Definition and characterization of an inflammatory phenotype in patients with COPD - results from the COSYCONET study
F. Seiler (Homburg, Germany), F. Trudzinski (Homburg, Germany), S. Fähndrich (Homburg, Germany), H. Watz (Grosshansdorf, Germany), R. Jörres (München, Germany), A. Koch (Hannover, Germany), T. Welte (Hannover, Germany), C. Vogelmeier (Marburg, Germany), F. Biertz (Hannover, Germany), R. Bals (Homburg, Germany)
| |
Predictors of lung function decline: a retrospective study in COPD patients
F. Spelta (Verona, Italy), M. Pizzini (Verona, Italy), L. Cazzoletti (Verona, Italy), V. Rigoni (Verona, Italy), F. Zamboni (Verona, Italy), P. Ferrari (Verona, Italy), G. Zambon (Verona, Italy), M. Ferrari (Verona, Italy)
| |
Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease
L. Chen (Changsha, China), X. He (Changsha, China), T. Li (Changsha, China), L. Luo (Changsha, China), Y. Chen (Changsha, China)
| |
Cytokines profile of blood and sputum in COPD exacerbation
S. Nesterovich (Tomsk, Russian Federation), E. Bukreeva (Tomsk, Russian Federation)
| |